doi:10.3969/j.issn.1671-2587.2020.03.004

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2020, Vol. 22 ›› Issue (3): 236-241.DOI: 10.3969/j.issn.1671-2587.2020.03.004

Previous Articles Next Articles

Received:2020-03-30 Online:2020-06-20 Published:2020-06-13

[1] Yang PH,Ding YB,Xu Z,et al. Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China[J/OL].Medrxiv, (2020-03-03). https://www.medrxiv.org/content/10.1101/2020.02.28.20028068v1.
[2] Pandey PK,Kaul E,Agarwal N,et al.Effectiveness of Therapeutic Plasma Exchange in a Critically Ill Child With Secondary Hemophagocytic Lymphohistiocytosis[J]. Asian J Transfus Sci,2019,13(2):145-147.
[3] Cohen S,Fishman P.Targeting the A₃ Adenosine Receptor to Treat Cytokine Release Syndrome in Cancer Immunotherapy[J]. Drug Des Devel Ther,2019,13:491-497.
[4] Shimabukuro-Vornhagen A,Gödel P,Subklewe M,et al.Cytokine Release Syndrome[J]. J Immunother Cancer,2018,6(1):56.
[5] Jiang H,Yang Z.Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis:A Case Report and Literature Review[J]. Front Pediatr,2020,8:93.
[6] Gardner RA,Ceppi F,Rivers J,et al.Preemptive Mitigation of CD19 CAR T-cell Cytokine Release Syndrome Without Attenuation of Antileukemic Efficacy[J]. Blood,2019,134(24):2149-2158.
[7] Giavridis T,van der Stegen SJC,Eyquem J,et al. CAR T Cell-Induced Cytokine Release Syndrome Is Mediated by Macrophages and Abated by IL-1 Blockade[J]. Nat Med,2018,24(6):731-738.
[8] Norelli M,Camisa B,Barbiera G,et al.Monocyte-derived IL-1 and IL-6 Are Differentially Required for Cytokine-Release Syndrome and Neurotoxicity Due to CAR T Cells[J]. Nat Med,2018,24(6):739-748.
[9] Sindel A,Taylor T,Chesney A,et al.Hematopoietic Stem Cell Mobilization Following PD-1 Blockade: Cytokine Release Syndrome After Transplantation Managed With Ascorbic Acid[J]. Eur J Haematol, 2019,103(2):134-136.
[10] Awasthi R,Pacaud L,Waldron E,et al.Tisagenlecleucel Cellular Kinetics, Dose, and Immunogenicity in Relation to Clinical Factors in Relapsed/Refractory DLBCL[J]. Blood Adv,2020,4(3):560-572.
[11] Grazioli A,Athale J,Tanaka K,et al. Perioperative Applications of Therapeutic Plasma Exchange in Cardiac Surgery: A Narrative Review[J/OL]. J Cardiothorac Vasc Anesth, (2020-02-08).https://www.clinicalkey.com/#!/content/journal/1-s2.0-S105307702030118X.
[12] 杨成民,刘进,赵桐茂,主编.中华输血学[M]. 北京:人民卫生出版社,2018:672-691.
[13] Bird L.Calming the Cytokine Storm[J]. Nat Rev Immunol,2018,18(7):417.
[14] Xiaoqiang Chai,Longfei Hu,Yan Zhang, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After2019-nCoV Infection[J/OL].BioRxiv,(2020-02-04). https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1.
[15] Suxin Wan,Qingjie Yi,Shibing Fan,et al. Charact-eristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with2019 novel coronavirus pneumonia (NCP)[J/OL].medRxiv,(2020-02-12). https://www.medrxiv.org/content/10.1101/2020.02.10.20021832v1.
[16] 国家感染性疾病临床医学研究中心, 传染病诊治国家重点实验室. 人工肝血液净化系统应用于重型、危重型新型冠状病毒肺炎治疗的专家共识[J] . 中华临床感染病杂志,2020,13(1): 1-3.
[17] 徐凯进,蔡洪流,沈毅弘,等.2019冠状病毒病(COVID-19)诊疗浙江经验[J/OL].浙江大学学报(医学版):1-12[2020-04-20].http://kns.cnki.net/kcms/detail/33.1248.R.20200222.1417.002.html.
[18] 国家卫生健康委办公厅,国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL].(2020-03-03). http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[19] Huang C,Wang Y,Li X,et al.Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China[J]. Lancet,2020,395(10223):497-506.
[20] Jing Liu,Sumeng Li,Jia Liu,et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients[J/OL].medRxiv.(2020-02-22). https://www.medrxiv.org/content/10.1101/2020.02.16.20023671v2.
[21] Jiahua He,Huanyu Tao,Yumeng Yan,et al. Molecular mechanism of evolution and human infection with the novel coronavirus(2019-nCoV)[J/OL]. biorxiv,(2020-02-21).https://www.biorxiv.org/content/10.1101/2020.02.17.952903v1.
[22] Yonggang Zhou,Binqing Fu,Xiaohu Zheng,et al. Aberrant pathogenic GM-CSF + T cells and inflammatory CD14+ CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus[J/OL]. biorxiv,(2020-02-20).https://www.biorxiv.org/content/10.1101/2020.02.12.945576v1.
[23] 骆嵩,杨丽娟,王春,等.血浆置换和托珠单抗治疗六例2019冠状病毒病(COVID-19)重型患者临床分析[J/OL].浙江大学学报(医学版):1-6[2020-04-20].http://kns.cnki.net/kcms/detail/33.1248.R.20200317.1146.002.html.
[24] Cooper CL.Pandemic H1N12009 Influenza and HIV:A Review of Natural History, Management and Vaccine Immunogenicity[J]. Curr Opin Infect Dis,2012,25(1):26-35.
[25] Patel P,Nandwani V,Vanchiere J,et al.Use of Therapeutic Plasma Exchange as a Rescue Therapy in 2009 pH1N1 Influenza A--an Associated Respiratory Failure and Hemodynamic Shock[J]. Pediatr Crit Care Med, 2011,12(2):e87-89.
[26] Kain T,Lindsay PJ,Adhikari NKJ,et al. Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome[J/OL]. Emerging Infect Dis,2020,26(6), https://doi.org/10.3201/eid2606.200037.
[27] Koch B,Schult-Dietrich P,Büttner S,et al.Lect-in Affinity Plasmapheresis for Middle East Respiratory Syndrome-Coronavirus and Marburg Virus Glycoprotein Elimination[J]. Blood Purif,2018,46(2):126-133.
[28] Jacob ST, Crozier I, Fischer WA 2nd, et al. Ebola virus disease[J].Nat Rev Dis Primers,2020,6(1):13.
[29] Büttner S,Koch B,Dolnik O,et al.Extracorporeal Virus Elimination for the Treatment of Severe Ebola Virus Disease--First Experience With Lectin Affinity Plasmapheresis[J]. Blood Purif,2014,38(3-4):286-291.
[30] Yang X,Yu Y,Xu J,et al. Clinical Course and Outcomes of Critically Ill Patients With SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study[J/OL]. Lancet Respir Med,2020, https://linkinghub.elsevier.com/retrieve/pii/S2213-2600(20)30079-5.
[31] Xu Z,Shi L,Wang Y,et al.Pathological Findings of COVID-19 Associated With Acute Respiratory Distress Syndrome[J]. Lancet Respir Med,2020, 8(4):420-422.
[32] Tsang K,Zhong NS.SARS:Pharmacotherapy[J]. Respirology,2003,8(Suppl):S25-S30.
[33] 菅宏蕴,周再生,欧秀燕,等.血浆置换联合连续性静脉-静脉血液滤过对急性呼吸窘迫综合征治疗的临床观察[J].中国实用医药,2008,3(26):6-8.
[34] Navarro-Martínez R,Cauli O.Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer's Disease and Chronic Progressive Multiple Sclerosis: A Review[J]. Pharmaceuticals , 2020, 13(2) : 28.
[35] Hall MW,Knatz NL,Vetterly C,et al.Immunoparalysis and Nosocomial Infection in Children With Multiple Organ Dysfunction Syndrome[J]. Intensive Care Med,2011,37(3):525-532.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141.
[2]	WANG Hui-ru, LIU Hui-lan. Factors Influencing Blood Transfusion in Patients after Unrelated Umbilical Cord Blood Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 162-166.
[3]	ZHANG Yuan-yuan, YING Mei-ai, PAN Jian, et al. The Clinical Effect of Plasma Exchange in ABO Incompatible Relatives in vivo Kidney Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 167-172.
[4]	WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185.
[5]	GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188.
[6]	DUAN Bing-zheng, WANG Shu-lian, LIAN Jun-hui, et al. Clinical Significance of Direct Anti-human Globulin Test in Patients' Blood Transfusion Effect [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 189-191.
[7]	YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196.
[8]	GUO Wei-jie, LIU Ze-ya, ZHANG Fan, et al. Meta-analysis：Unexpected Antibody Positive Rate of Blood Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 202-212.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 236-239.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 239-241.
[11]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 248-255.
[12]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 259-262.
[13]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 268-272.
[14]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 13-17.
[15]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 587-589.